Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.27 USD | -1.69% | -6.80% | -17.44% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- EVH Stock
- Revisions Evolent Health, Inc.